MiNK Therapeutics's total assets for Q3 2025 were $14.96B, a decrease of ― from the previous quarter. INKT total liabilities were $0.00 for the fiscal quarter, a ― a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.